These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29217233)

  • 1. Pro: Factor Concentrates are Essential for Hemostasis in Complex Cardiac Surgery.
    Ghadimi K; Welsby IJ
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):558-564. PubMed ID: 29217233
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic agents for bleeding: recombinant-activated factor VII and beyond.
    Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
    Semin Thromb Hemost; 2015 Apr; 41(3):342-7. PubMed ID: 24937097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review.
    Lin DM; Murphy LS; Tran MH
    Transfus Med Rev; 2013 Apr; 27(2):91-104. PubMed ID: 23462530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential value of transfusion protocols in cardiac surgery.
    Görlinger K; Dirkmann D; Hanke AA
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):230-43. PubMed ID: 23407150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH.
    Godier A; Greinacher A; Faraoni D; Levy JH; Samama CM
    J Thromb Haemost; 2018 Jan; 16(1):170-174. PubMed ID: 29168325
    [No Abstract]   [Full Text] [Related]  

  • 8. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery.
    Tanaka KA; Mazzeffi MA; Grube M; Ogawa S; Chen EP
    Transfusion; 2013 Apr; 53(4):920-1. PubMed ID: 23565996
    [No Abstract]   [Full Text] [Related]  

  • 9. Current use of factor concentrates in pediatric cardiac anesthesia.
    Guzzetta NA; Williams GD
    Paediatr Anaesth; 2017 Jul; 27(7):678-687. PubMed ID: 28393462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
    Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
    Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.
    Chow JH; Lee K; Abuelkasem E; Udekwu OR; Tanaka KA
    Semin Cardiothorac Vasc Anesth; 2018 Jun; 22(2):164-173. PubMed ID: 29099345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical techniques to control massive bleeding.
    Zentai C; Grottke O; Spahn DR; Rossaint R
    Anesthesiol Clin; 2013 Mar; 31(1):41-53. PubMed ID: 23351533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis.
    Lisman T; Kleiss S; Patel VC; Fisher C; Adelmeijer J; Bos S; Singanayagam A; Stoy SH; Shawcross DL; Bernal W
    Liver Int; 2018 Nov; 38(11):1988-1996. PubMed ID: 29768734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of prothrombin complex concentrates in anticoagulation.
    van Veen SQ; Strengers PF
    Am J Hematol; 2008 Apr; 83(4):344-5. PubMed ID: 18213649
    [No Abstract]   [Full Text] [Related]  

  • 15. PRO: Prothrombin Complex Concentrate Should Be Used in Preference to Fresh Frozen Plasma for Hemostasis in Cardiac Surgical Patients.
    Bhatt HV; Subramaniam K
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1062-1067. PubMed ID: 29336960
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry.
    Furukawa S; Nogami K; Ogiwara K; Yada K; Minami H; Shima M
    J Thromb Haemost; 2015 Jul; 13(7):1279-84. PubMed ID: 25903848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders.
    Ragni MV
    Hematology Am Soc Hematol Educ Program; 2013; 2013():44-51. PubMed ID: 24319161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
    Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.